13F Pro quality score
Rank #2,574 of 2,884
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from DNA X, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2024 | 10-K | $58.3M | $-33.6M | -5.3% |
| FY 2023 | 10-K | $93.6M | $-90.0K | 0.5% |
| FY 2022 | 10-K | $69.8M | $-14.1M | -20.5% |
| FY 2021 | 10-K/A | $54.6M | $-38.6M | -69.6% |
| FY 2020 | 10-K/A | $64.0M | $-29.9M | -45.7% |
| FY 2019 | 10-K | $116.3M | $-25.8M | -19.3% |
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
DNA X, Inc. (SONM) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores SONM at 26.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,574 of 2,884 stocks — the bottom half of the AI-ranked universe. SONM scores in the top quartile across balance sheet strength (94.5). Areas of concern include earnings quality (1.2) and revenue growth (3.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 33.1/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of SONM by reported 13-F value include C2C Wealth Management, BlackRock, CITADEL ADVISORS, based on the most recent SEC filings. SONM trades on the Nasdaq exchange and files with the SEC under CIK 1178697. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SONM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DNA X, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1178697 →